The FDA is now calling for warning labels on all commercial CAR-T therapy products amid its investigation into 22 reports about a possible being linked to lymphoma.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA calls for warning labels on commercial CAR-T therapies amid cancer probe
